Zelluna ASA (ZLNA)

Currency in NOK
22.40
-0.70(-3.03%)
Real-time Data·
Earnings results expected in 13 days
ZLNA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
22.4024.00
52 wk Range
8.2035.80
Key Statistics
Prev. Close
23.1
Open
24
Day's Range
22.4-24
52 wk Range
8.2-35.8
Volume
5.58K
Average Volume (3m)
58.8K
1-Year Change
31.7647%
Book Value / Share
3.27
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ZLNA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Zelluna ASA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Zelluna ASA, a clinical-stage biotechnology company, engages in the development of T-cell receptor guided natural killer cell therapies in Norway. It develops ZI-MA4-1 which is in Phase I clinical trial for the treatment of non-small cell lung cancer, ovarian, and head and neck synovial sarcoma; ZI-KL1-1 which is in preclinical trial for the treatment of breast, gastric, lung, pancreatic, and cervix cancers; and ZI-PR-1 which is in discovery stage for the treatment of solid tumors. The company was incorporated in 2016 and is headquartered in Oslo, Norway.

Zelluna ASA Earnings Call Summary for Q3/2025

  • Zelluna reported a Q3 2025 negative EBIT of NOK 40 million with a successful capital raise of NOK 58 million, extending cash runway to Q1 2027 despite 3.95% stock price drop.
  • The company's TCR-NK platform shows strategic advancement with plans to submit a Clinical Trial Application in H2 2025 and expects initial patient data by mid-2026.
  • Financial position includes a cash balance of NOK 47 million and year-to-date EBIT loss of NOK 101 million, with guidance projecting negative EPS for FY2025 and FY2026.
  • CEO Namir Hassan highlighted optimized manufacturing processes for the TCR-NK platform and emphasized the potent killing capabilities of natural killer cells.
  • Zelluna plans a safety and initial efficacy strategy with three-patient cohorts while remaining open to strategic business development opportunities based on early-stage data.
Last Updated: 04/11/2025, 09:12
Read Full Transcript

Compare ZLNA to Peers and Sector

Metrics to compare
ZLNA
Peers
Sector
Relationship
P/E Ratio
−4.3x−2.0x−0.4x
PEG Ratio
−0.05−0.040.00
Price/Book
7.1x2.1x2.6x
Price / LTM Sales
-5.6x3.2x
Upside (Analyst Target)
-330.3%46.7%
Fair Value Upside
Unlock26.9%7.6%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
11/02/2026
EPS / Forecast
-1.50 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Zelluna (Oslo: ZLNA) Share Price Today?

The Zelluna stock price today is 22.40 NOK.

What Stock Exchange Does Zelluna (ZLNA) Trade On?

Zelluna is listed and trades on the Oslo Stock Exchange.

What Is the Ticker (Stock Symbol) for Zelluna?

The stock symbol (also called a 'ticker') for Zelluna is "ZLNA."

What Is the Current Zelluna Market Capitalisation?

As of today, Zelluna (Oslo: ZLNA) market cap is 606.83M NOK.

What Is Zelluna's (ZLNA) Earnings Per Share (TTM)?

The Zelluna EPS is currently -7.08 (Trailing Twelve Months).

When Is the Next Zelluna Earnings Date?

Zelluna's next earnings report will be released on 07/05/2026.

Is ZLNA a Buy or Sell From a Technical Analyst Perspective?

Based on today's Zelluna moving averages and other technical indicators, the daily buy/sell signal for ZLNA stock is Buy.

How Many Times Has Zelluna Stock Split?

Zelluna has split 1 times. (See the ZLNA stock split history page for full effective split date and price information.)

How Many Employees Does Zelluna Have?

Zelluna has 24 employees, based on their latest Companies House report.

What is the current trading status of Zelluna (Oslo: ZLNA)?

As of 24/04/2026, Zelluna (ZLNA) is trading at a share price of 22.40 NOK, with a previous close of 23.10 NOK. The stock has fluctuated within a day range of 22.40 NOK to 24.00 NOK, while its 52-week range spans from 8.20 NOK to 35.80 NOK.

Industry Spotlight

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.